Cardiol Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Cardiol Therapeutics Total Assets Growth & History (CRDL)
Cardiol Therapeutics's total assets was $23.6M for fiscal 2025.
View full Cardiol Therapeutics company overviewCardiol Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $23.6M | −$8.2M | −25.87% |
| 2024 | 2024-12-31 | $31.9M | −$4.8M | −13.18% |
| 2023 | 2023-12-31 | $36.7M | −$25.3M | −40.83% |
| 2022 | 2022-12-31 | $62.0M | −$25.8M | −29.41% |
| 2021 | 2021-12-31 | $87.9M | $72.0M | +452.92% |
| 2020 | 2020-12-31 | $15.9M | — | — |
Cardiol Therapeutics quarterly total assets
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $29.4M | $9.4M | +47.25% |
| Q1 2026 | 2026-03-31 | $31.4M | $6.0M | +23.38% |
| Q4 2025 | 2025-12-31 | $23.6M | −$8.2M | −25.87% |
| Q3 2025 | 2025-09-30 | $12.9M | — | — |
| Q2 2025 | 2025-06-30 | $19.9M | — | — |
| Q1 2025 | 2025-03-31 | $25.5M | — | — |
| Q4 2024 | 2024-12-31 | $31.9M | −$4.8M | −13.18% |
| Q4 2023 | 2023-12-31 | $36.7M | −$25.3M | −40.83% |
| Q4 2022 | 2022-12-31 | $62.0M | −$25.8M | −29.41% |
| Q4 2021 | 2021-12-31 | $87.9M | $72.0M | +452.92% |
| Q4 2020 | 2020-12-31 | $15.9M | — | — |
Cardiol Therapeutics total assets trends
Over the last five fiscal years, Cardiol Therapeutics's total assets increased from $15.9M to $23.6M, a change of $7.7M. The latest reported quarter, Q2 2026, shows $29.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cardiol Therapeutics source filings ↗